User Name:


remember me

Forgot your password?

Not a member?

Join Now

News Topic - FDA

RSS feedDisplaying articles 1 - 10 of most recent articles

Photo from
FDA warns consumers of fraudulent Ebola treatment products The FDA is advising consumers to be aware of fraudulent products being sold online, claiming to prevent or treat the Ebola virus. The agency has received several consumer complaints about a variety of products touting their ability to cure the deadly dise | 12 hours, 8 minutes ago | comment? | recommend article from Oklahoma City, Oklahoma
FDA: No diet supplement can treat concussions Athletes and veterans have been targeted by unregulated products that falsely claim to treat traumatic brain injuries
CBS News | 13 hours, 1 minute ago | comment? | recommend
Many voice support for the view that biotech's model is falling apart I got a lot of feedback from a blog post yesterday in which a former commissioner of the FDA, Andrew von Eschenbach, criticized the agency he used to head, saying its effectively holding back innovation. Probably the most memorable quote (and headline) wa | 16 hours, 10 minutes ago | comment? | recommend article from Boston, Massachusetts
Feds Seek Comments on 'Modified Risk' Tobacco FDA seeks comments on Swedish Match's request to sell snus products as 'modified risk' tobacco
ABC News | 20 hours, 45 minutes ago | comment? | recommend
NAFTA Tribunal Decision Supports FDA and Its Actions TORONTO, Aug. 26, 2014 /CNW/ -Apotex Inc., the largest Canadian owned pharmaceutical company, announced today that an arbitration tribunal rejected Apotex's claims that the FDA violated NAFTA by p...
Canada NewsWire | 22 hours, 20 minutes ago | comment? | recommend
Photo from KFDA - NewsChannel 10
DEA and FDA to enforce stricter rules on hydrocodone combination pills Amarillo, TX - In order to decrease prescription drug overdoses, the drug enforcement administration is attempting to enforce stricter rules on prescribed hydrocodone combination pills.
KFDA - NewsChannel 10 | Aug 26, 2014 12:22 AM [GMT] | comment? | recommend article from Amarillo, Texas
ViiV Healthcare recibe aprobacin de la FDA para Triumeq (abacavir, dolutegravir y lamivudine), una nueva rgimen de tableta nica para el tratamiento de El material multimedia relacionado con el aviso a continuación ya está disponible. El material incluye: material complementario en video, fragmentos corporativos de sonido, imágenes de producto e información adicional. Por favor visite
PR Newswire | Aug 25, 2014 11:32 PM [GMT] | comment? | recommend
Up 35% on Buyout: InterMune inc Investor Key Takeaways FDA's rejection of InterMune's Esbriet hurt investors, but Roche clearly thinks the drug will be approved. | Aug 25, 2014 8:38 PM [GMT] | comment? | recommend
FDA names potential Insys treatment an orphan drug A potential treatment from Insys Therapeutics Inc. for an aggressive form of brain cancer will have some marketing exclusivity if regulators eventually approve it. The Food and Drug Administration has ...
Yahoo! News | Aug 25, 2014 2:17 PM [GMT] | comment? | recommend
Former FDA head says biotech business model 'is basically falling apart' A former head of the U.S. Food and Drug Administration who will help lead a discussion at Tufts University today says that the agency is holding back, rather than encouraging, the creation of groundbreaking new drugs. Andrew von Eschenbach, commissioner o | Aug 25, 2014 12:54 PM [GMT] | comment? | recommend article from Boston, Massachusetts